Figure 2.
AlloMap Kidney differentiates quiescence from rejection in a single-center validation set. (A) Biopsy specimen–defined rejection (n=11) is significantly different from biopsy specimen–defined no rejection (n=8). (B) All three rejection groups are elevated relative to NR (NR, n=8; TCMR, n=7; ABMR, n=2; mixed rejection, n=2). (C) Receiver operating characteristic plot for the second validation set NR versus rejection (TCMR, ABMR, and mixed rejection). Unpaired t test.